Knight Therapeutics Inc. (TSX:GUD)

Canada · Delayed Price · Currency is CAD

9.84

+0.07 (0.72%)

Jul 31, 2026, 4:00 PM EST

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	450.09M	371.30M	328.20M	293.56M	243.48M
Total	450.09M	371.30M	328.20M	293.56M	243.48M

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Canada	84.28M	25.69M	19.67M	11.35M	7.70M
Brazil	182.52M	180.63M	168.22M	134.73M	97.20M
Argentina	40.75M	45.90M	24.10M	46.13M	42.96M
Colombia	55.00M	51.48M	44.63M	48.15M	43.52M
Mexico	24.50M	18.99M	15.89M	-	-
Rest of The Latin America	43.02M	38.83M	39.22M	40.17M	40.95M
Other	20.02M	9.78M	16.48M	13.05M	11.15M
Total	450.09M	371.30M	328.20M	293.56M	243.48M